Literature DB >> 20655113

Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?

R Correa1, H Akiskal, W Gilmer, A A Nierenberg, M Trivedi, S Zisook.   

Abstract

BACKGROUND: There is widespread clinical belief that unrecognized bipolar disorder (BD) is a frequent contributor to apparent treatment resistant depression (TRD). This review attempts to assess the degree to which prevailing empirical data supports that view.
METHODS: All English-language articles published between January 1998 and January 2008 that focused on adults with major depressive disorder (MDD) and BD bearing on the question "Is unrecognized BD a frequent contributor to apparent TRD in patients initially diagnosed with MDD?" were reviewed.
RESULTS: 196 articles were reviewed; the preponderance of the data suggested: 1) TRD populations demonstrate high rates of hidden bipolar disorder, 2) there is not sufficient evidence to unequivocally support or reject the hypothesis that patients who relapse despite continued antidepressant treatment are likely to have bipolar spectrum disorder, 3) patients initially diagnosed with MDD do not demonstrate high rates of switching to mania or hypomania when treated with antidepressants and 4) in patients diagnosed with BD, antidepressants are not robustly effective and are poorly tolerated. LIMITATIONS: The main limitation of this review is that none of the individual studies were designed to test our primary hypothesis.
CONCLUSIONS: This review provides at least moderate support to the hypothesis that BD is a contributor to apparent TRD. Thus, clinicians treating MDD are urged to search for "soft" signs of bipolarity and to be prepared to alter diagnosis and treatment strategies accordingly. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655113     DOI: 10.1016/j.jad.2010.06.036

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  26 in total

1.  A Case of Major Depressive Disorder With Mixed Features: Diagnostic and Treatment Issues.

Authors:  Verinder Sharma; Rudy Bowen; Priya Sharma
Journal:  Prim Care Companion CNS Disord       Date:  2015-07-30

2.  Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents? A latent class analysis from the TORDIA study.

Authors:  Fadi T Maalouf; Giovanna Porta; Benedetto Vitiello; Graham Emslie; Taryn Mayes; Gregory Clarke; Karen D Wagner; Joan Rosenbaum Asarnow; Anthony Spirito; Martin Keller; Boris Birmaher; Neal Ryan; Wael Shamseddeen; Satish Iyengar; David Brent
Journal:  J Affect Disord       Date:  2012-01-30       Impact factor: 4.839

3.  Identification and management of cryptic bipolarity in patients with TRD.

Authors:  Verinder Sharma
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

4.  Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.

Authors:  Ebrahim Haroon; Alexander W Daguanno; Bobbi J Woolwine; David R Goldsmith; Wendy M Baer; Evanthia C Wommack; Jennifer C Felger; Andrew H Miller
Journal:  Psychoneuroendocrinology       Date:  2018-05-19       Impact factor: 4.905

5.  Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.

Authors:  Lori L Davis; Patricia Pilkinton; Stephen R Wisniewski; Madhukar H Trivedi; Bradley N Gaynes; Robert H Howland; Sidney Zisook; G K Balasubramani; Maurizio Fava; A John Rush
Journal:  Depress Anxiety       Date:  2012-02       Impact factor: 6.505

6.  Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  J Affect Disord       Date:  2019-04-08       Impact factor: 4.839

7.  Adjuvant valproate therapy for patients with suspected mixed-depressive features.

Authors:  Chen-Chung Liu
Journal:  Ther Adv Psychopharmacol       Date:  2014-08

8.  Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression.

Authors:  Amany K Hassan; Kevin C Farmer; Nancy C Brahm; Barbara R Neas
Journal:  Int J Clin Pharm       Date:  2016-03-02

Review 9.  Bipolar disorder diagnosis: challenges and future directions.

Authors:  Mary L Phillips; David J Kupfer
Journal:  Lancet       Date:  2013-05-11       Impact factor: 79.321

10.  Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial.

Authors:  Jonathan Savitz; Sheldon Preskorn; T Kent Teague; Douglas Drevets; William Yates; Wayne Drevets
Journal:  BMJ Open       Date:  2012-02-22       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.